Sheel Biotech Limited (NSE:SHEEL)
India · Delayed Price · Currency is INR 60.00
-2.05 (-3.30%)
At close: Aug 21, 2026
Sheel Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 117.56 | 106.36 | 104.75 | 50.77 | 45.1 |
Depreciation & Amortization | 10.66 | 9 | 9.87 | 10.17 | 9.4 |
Loss (Gain) From Sale of Assets | 0.45 | -1.13 | - | - | -0.29 |
Loss (Gain) From Sale of Investments | - | -1.88 | - | - | - |
Other Operating Activities | 16.24 | 17.75 | 19.47 | 28.02 | 10.41 |
Change in Accounts Receivable | -67.26 | 26.22 | -16.55 | 86.61 | -40.22 |
Change in Inventory | 98.2 | -66.11 | -134.74 | -74.72 | -55.53 |
Change in Accounts Payable | -3.02 | -4.46 | -36.17 | -1.37 | 49.35 |
Change in Other Net Operating Assets | -348.52 | 6.33 | 44.19 | -6.55 | 3.68 |
Operating Cash Flow | -175.69 | 92.08 | -9.2 | 92.92 | 21.91 |
Operating Cash Flow Growth | - | - | - | 324.19% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -66.6 | -12.38 | -2.94 | -11.55 | -12.09 |
Sale of Property, Plant & Equipment | 1.05 | 2 | - | - | 0.52 |
Investment in Securities | - | 1.98 | - | - | -7.92 |
Other Investing Activities | -0.13 | -14.1 | 0.42 | -10.21 | -1.67 |
Investing Cash Flow | -65.68 | -22.51 | -2.52 | -21.75 | -21.16 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 1,095 | 1,161 | 979.32 | 3.98 |
Long-Term Debt Issued | - | 48.45 | 20.89 | 32.91 | 18.39 |
Total Debt Issued | - | 1,143 | 1,182 | 1,012 | 22.37 |
Short-Term Debt Repaid | - | -1,102 | -1,126 | -984.01 | - |
Long-Term Debt Repaid | -35.79 | -102.9 | -12.62 | -72.34 | - |
Total Debt Repaid | -35.79 | -1,205 | -1,138 | -1,056 | - |
Net Debt Issued (Repaid) | -35.79 | -61.78 | 43.69 | -44.12 | 22.37 |
Issuance of Common Stock | 356.15 | 20.23 | - | - | - |
Common Dividends Paid | - | -14.95 | -13.26 | -12.84 | -12.85 |
Other Financing Activities | -61.81 | -14.46 | -14.79 | -15.21 | -11.78 |
Financing Cash Flow | 258.56 | -70.96 | 15.64 | -72.17 | -2.26 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 17.19 | -1.39 | 3.93 | -1 | -1.51 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -242.28 | 79.7 | -12.14 | 81.38 | 9.81 |
Free Cash Flow Growth | - | - | - | 729.34% | - |
Free Cash Flow Margin | -22.02% | 7.83% | -1.31% | 10.16% | 1.39% |
Free Cash Flow Per Share | -13.79 | 5.40 | -0.84 | 5.61 | 0.68 |
Levered Free Cash Flow | -261.42 | 42.92 | -52.53 | 38.35 | -26.53 |
Unlevered Free Cash Flow | -249.45 | 51.95 | -45.34 | 45.34 | -20.91 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 19.15 | 14.46 | 11.5 | 11.17 | 9 |
Cash Income Tax Paid | 22.97 | 19.9 | 13.24 | 0.02 | 1.78 |
Change in Working Capital | -320.6 | -38.02 | -143.28 | 3.97 | -42.72 |